Thursday 6 September | |
PPHE Hotel Group | Half Year Results |
Hunters Property | Half Year Results |
International PPL | Half Year Results |
Mpac Group | Half Year Results |
Deepmatter Group | Half Year Results |
Melrose Industries | Half Year Results |
Dixons Carphone | Q1 Results |
McCarthy & Stone | Trading Statement |
Bovis Homes | Half Year Results |
Genus | Full Year Results |
Redde | Full Year Results |
Go-Ahead Group | Full Year Results |
McBride | Full Year Results |
Just Group | Half Year Results |
Bakkavor | Half Year Results |
International Public Partnerships | Half Year Results |
easyJet | August Traffic Statistics |
Friday 7 September | |
Secure Income REIT | Half Year Results |
Ashmore Group | Full Year Results |
Enquest | Half Year Results |
Greene King | Trading Statement |
Pacific Horizon Investment Trust | Full Year Results |
Monday 10 September | |
Abcam | Full Year Results |
Associated British Foods | Trading Statement |
HGCapital Trust | Half Year Results |
Gulf Keystone Petroleum | Half Year Results |
Brady | Half Year Results |
Tuesday 11 September | |
Ashtead Group | Q1 Results |
JD Sports Fashion | Half Year Results |
Sanne Group | Half Year Results |
Midwich Group | Half Year Results |
Alumasc Group | Full Year Results |
Vectura Group | Half Year Results |
Cairn Energy | Half Year Results |
Hilton Food | Half Year Results |
Harworth | Half Year Results |
EU Supply | Half Year Results |
DP Eurasia | Half Year Results |
Puretech Health | Half Year Results |
Surgical Innovations | Half Year Results |
Silence Therapeutics | Half Year Results |
Wednesday 12 September | |
Galliford Try | Full Year Results |
Property Franchise | Half Year Results |
iGas | Half Year Results |
1pm | Half Year Results |
Epwin Group | Half Year Results |
Ten Entertainment | Half Year Results |
Futura Medical | Half Year Results |
Dunelm Group | Full Year Results |
Wilmington | Full Year Results |
Medica Group | Half Year Results |
Safestore Holdings | Q3 Results |
Charles Taylor | Half Year Results |
Advanced Medical Solutions Group | Half Year Results |
IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia
Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.
Read more